| 1. |
Robertson, M. J., and J. Ritz. (1990). Biology and clinical relevance of human natural killer cells. Blood
76:2421.
|
| |
| 2. |
Campbell, J. J., S. Qin, D. Unutmaz, D. Soler, K. E. Murphy, M. R. Hodge, L. Wu, and E. C. Butcher. (2001). Unique subpopulations
of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol.
166:6477.
|
| |
| 3. |
Jacobs, R., G. Hintzen, A. Kemper, K. Beul, S. Kempf, G. Behrens, K. W. Sykora, and R. E. Schmidt. (2001). CD56bright cells
differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur. J. Immunol.
31:3121.
|
| |
| 4. |
Cooper, M. A., T. A. Fehniger, S. C. Turner, K. S. Chen, B. A. Ghaheri, T. Ghayur, W. E. Carson, and M. A. Caligiuri. (2001).
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood
97:3146.
|
| |
| 5. |
Fehniger, T. A., M. A. Cooper, G. J. Nuovo, M. Cella, F. Facchetti, M. Colonna, and M. A. Caligiuri. (2003). CD56bright natural
killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive
and innate immunity. Blood
101:3052.
|
| |
| 6. |
Ferlazzo, G., D. Thomas, S.-L. Lin, K. Goodman, B. Morandi, W. A. Muller, A. Moretta, and C. Munz. (2003). The abundant NK
cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
J. Immunol.
172:1455.
|
| |
| 7. |
Westermann, J., and R. Pabst. (1992). Distribution of lymphocyte subsets and natural killer cells in the human body. Clin. Invest.
70:539.
|
| |
| 8. |
Trepel, F. (1974). Number and distribution of lymphocytes in man: a critical analysis. Klin. Wochenschr.
52:511.
|
| |
| 9. |
Freud, A. G., B. Becknell, S. Roychowdhury, H. C. Mao, A. K. Ferketich, G. J. Nuovo, T. L. Hughes, T. B. Marburger, J. Sung,
R. A. Baiocchi, M. Guimond, and M. A. Caligiuri. (2005). A human CD34(+) subset resides in lymph nodes and differentiates
into CD56bright natural killer cells. Immunity
22:295–304.
|
| |
| 10. |
Loza, M. J., and B. Perussia. (2004). The IL-12 signature: NK cell terminal CD56+high stage and effector functions. J. Immunol. 172:88–96.
|
| |
| 11. |
Mailliard, R. B., S. M. Alber, H. Shen, S. C. Watkins, J. M. Kirkwood, R. B. Herberman, and P. Kalinski. (2005). IL-18-induced
CD83+CCR7+ NK helper cells. J. Exp. Med. 202:941–953.
|
| |
| 12. |
Hastie, N. D., M. Dempster, M. G. Dunlop, A. M. Thompson, D. K. Green, and R. C. Allshire. (1990). Telomere reduction in human
colorectal carcinoma and with ageing. Nature
346:866–868.
|
| |
| 13. |
Figueroa, R., H. Lindenmaier, M. Hergenhahn, K. V. Nielsen, and P. Boukamp. (2000). Telomere erosion varies during in vitro aging of normal human fibroblasts from young and adult donors. Cancer Res. 60:2770–2774.
|
| |
| 14. |
Weng, N. P., B. L. Levine, C. H. June, and R. J. Hodes. (1995). Human naive and memory T lymphocytes differ in telomeric length
and replicative potential. Proc. Natl. Acad. Sci. U. S. A. 92:11091–11094.
|
| |
| 15. |
Rufer, N., W. Dragowska, G. Thornbury, E. Roosnek, and P. M. Lansdorp. (1998). Telomere length dynamics in human lymphocyte
subpopulations measured by flow cytometry. Nat. Biotechnol.
8:743–747.
|
| |
| 16. |
Serakinci, N., and J. Koch. (1999). Detection and sizing of telomeric repeat DNA in situ. A performance comparison of PRINS
and PNA assays. Nat. Biotechnol. 17:200–201.
|
| |
| 17. |
Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. (2003). Sensitive and
viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods
281:65–78.
|
| |
| 18. |
Penack, O., C. Gentilini, L. Fischer, A. M. Asemissen, C. Scheibenbogen, E. Thiel, and L. Uharek. (2005). CD56dimCD16neg cells
are responsible for natural cytotoxicity against tumor targets. Leukemia
19:835–840.
|
| |
| 19. |
Hultdin, M., E. Grönlund, K.-F. Norrback, E. Eriksson-Lindström, T. Just, and G. Roos. (1998). Telomere analysis by fluorescence
in situ hybridization and flow cytometry. Nucleic Acids Res. 26:3651–3656.
|
| |